✦ LIBER ✦

Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist

✍ Scribed by Xiujiang (Susie) Li; Jace Nielsen; Brenda Cirincione; Hankun Li; Carol Addy; John Wagner; Alan Hartford; Ngozi Erondu; Ira Gantz; Jerry Morgan; Julie Stone

Book ID: 111767665
Publisher: American Association of Pharmaceutical Scientists
Year: 2010
Tongue: English
Weight: 280 KB
Volume: 12
Category: Article
ISSN: 1550-7416
DOI: 10.1208/s12248-010-9212-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of taranabant, a cannabinoid-1

Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarin

✍ Jules I. Schwartz; Stephanie Dunbar; Jinyu Yuan; Susie Li; Adrianna Gipson; Kim 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 304 KB

Pharmacokinetics of digoxin in healthy s

Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist

✍ Andrew E. Denker; Gaetano Morelli; Laura K. Vessey; Susie Li; Jinyu Yuan; Stepha 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 928 KB

The Discovery of Taranabant, a Selective

The Discovery of Taranabant, a Selective Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

✍ William K. Hagmann 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 817 KB

ChemInform Abstract: The Discovery of Ta

ChemInform Abstract: The Discovery of Taranabant, a Selective Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity

✍ William K. Hagmann 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 23 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

ChemInform Abstract: Convenient Total Sy

ChemInform Abstract: Convenient Total Synthesis of Taranabant (MK-0364), a Novel Cannabinoid-1 Receptor Inverse Agonist as an anti-Obesity Agent.

✍ Min-ah Kim; Jong Yup Kim; Kwang-Seop Song; Jeongmin Kim; Jinhwa Lee 📂 Article 📅 2008 🏛 John Wiley and Sons ⚖ 18 KB 👁 1 views

Population Pharmacokinetics of Cycloplat

Population Pharmacokinetics of Cycloplatam. I. Development of the Population Model for Description of the Pharmacokinetic and Pharmacodynamic Processes Involving Cycloplatam

✍ A. S. Singin 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 89 KB